FONR · As filed with the SEC
Fonar cash flow statement, by fiscal year
The statement as Fonar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Jun 30, 2025 | FY2024 Year ended Jun 30, 2024 | FY2023 Year ended Jun 30, 2023 | FY2022 Year ended Jun 30, 2022 | FY2021 Year ended Jun 30, 2021 | FY2020 Year ended Jun 30, 2020 | FY2019 Year ended Jun 30, 2019 | FY2018 Year ended Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|
| Consolidated Net Income | 10,673,433 | — | — | — | — | — | — | — |
| Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ||||||||
| Depreciation Expense | — | — | 4,540,135 | 4,535,236 | 4,081,687 | 3,908,648 | 3,836,491 | 3,899,851 |
| Depreciation Expense | 4,698,321 | 4,596,421 | — | — | — | — | — | — |
| Provision for credit losses | 3,206,756 | 1,882,061 | 5,513,476 | 1,343,533 | 5,585,989 | 5,695,420 | (978,730) | (614,680) |
| Income Tax Expense | 823,660 | 2,795,507 | 2,979,550 | 3,093,893 | 2,855,006 | 2,118,829 | 1,755,520 | (4,919,750) |
| Income tax receivable | — | — | — | — | 671,185 | 528,815 | — | (1,200,000) |
| Compensatory element of stock issuances | — | — | — | — | — | — | — | 0 |
| Net Cash from Operating Activities | — | 4,311,762 | 4,264,818 | 4,000,131 | 1,458,053 | 1,005,560 | — | — |
| Compensatory element of stock issuances | — | — | — | — | 83,277 | — | — | — |
| Net Cash from Operating Activities | — | — | — | — | 1,940,821 | 1,990,380 | 1,954,745 | — |
| Abandoned patents | — | — | — | — | 534 | — | — | — |
| Loss on disposition of fixed assets | — | — | 213,244 | — | — | — | — | — |
| Gain on forgiveness of PPP loan | — | — | — | (700,764) | — | — | — | — |
| Net change in operating right-of-use assets and lease liabilities | (493) | — | — | — | — | — | — | — |
| Gain on sale of equipment – related party | — | (581,183) | — | — | — | — | — | — |
| Gain on disposition of fixed assets | — | (75,411) | — | — | — | — | — | — |
| Abandoned patents | 55,707 | 225,419 | — | — | — | — | — | — |
| Changes in operating assets and liabilities, net: | ||||||||
| Accounts, medical and management fee receivables | — | — | (8,055,843) | — | — | — | — | — |
| Notes receivable | — | — | (64,532) | 43,334 | 46,944 | 28,889 | (12,689) | (894,665) |
| Costs and estimated earnings in excess of Billings on uncompleted contracts | — | — | — | — | — | 372,277 | (438,472) | 649,423 |
| Contract assets | — | — | — | — | 152,833 | — | — | — |
| Accounts, medical and management fee receivable(s) | (9,005,766) | (11,676,139) | — | (5,602,188) | (12,110,859) | (10,797,456) | (6,134,095) | (4,328,239) |
| Notes receivable | — | 55,200 | — | — | — | — | — | — |
| Notes receivable – related party | 26,326 | — | — | — | — | — | — | — |
| Inventories | (97,241) | (145,775) | (209,845) | (696,402) | (14,649) | 149,396 | (366,786) | 192,882 |
| Prepaid expenses and other current assets | — | — | (438,911) | 90,638 | 526,425 | (133,287) | (79,641) | (1,553) |
| Prepaid expenses and other current assets | (1,194,922) | 266,606 | — | — | — | — | — | — |
| Other assets | 5,467 | 42,359 | 2,763 | 129,411 | (18,087) | (161,350) | 329 | 15,008 |
| Accounts payable | — | — | 19,685 | — | — | — | — | — |
| Accounts payable | (553,562) | 276,639 | — | (314,766) | (99,224) | 104,032 | 560,977 | (122,967) |
| Other current liabilities | 2,655,567 | 2,949,962 | (2,527,100) | (3,765,215) | 1,382,497 | 3,556,437 | (980,394) | 525,113 |
| Customer advances | — | — | — | — | — | 55,928 | (59,544) | 70,311 |
| Customer advances | (89,227) | (158,906) | 241,132 | (369,856) | (123,478) | — | — | — |
| Operating lease liabilities | — | — | — | (3,437,743) | (965,825) | 159,657 | — | — |
| Operating lease liabilities | — | — | (3,862,814) | — | — | — | — | — |
| Financing lease liabilities | — | — | (210,353) | (202,741) | (74,698) | — | — | — |
| Contract liabilities | — | — | — | (14,739) | 14,739 | — | — | — |
| Other liabilities | — | — | — | (64,790) | 21,020 | 115,855 | 11,943 | 16,404 |
| Due to related party medical practices | — | — | — | — | — | — | (134,880) | — |
| Other liabilities | — | — | (64,791) | — | — | — | — | — |
| Net Cash from Operating Activities | — | (4,541,352) | — | — | — | — | — | — |
| Finance lease liabilities | (79,970) | (217,569) | — | — | — | — | — | — |
| Other liabilities | 140,826 | (9,724) | — | — | — | — | — | — |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 11,264,882 | 14,093,294 | 14,467,130 | 15,301,360 | 19,088,001 | 20,402,763 | 19,448,448 | 18,739,323 |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Purchases of property and equipment | (3,791,581) | (789,961) | (4,218,084) | (4,545,292) | (3,533,091) | (7,522,997) | (3,355,456) | (2,777,948) |
| Proceeds from Investments | — | — | — | — | — | 15,062,932 | — | — |
| Purchase of Short term investment | — | — | — | — | — | — | (15,094,816) | — |
| Acquisitions, Net of Cash | — | — | — | — | — | — | — | (58,274) |
| Proceeds (Purchase) from short-term investment | 15,608 | (103,303) | (473) | (149) | (293) | — | — | — |
| Purchase of imaging center | — | — | — | — | (1,122,508) | — | — | — |
| Purchase of noncontrolling interests | — | — | — | (546,000) | — | — | — | — |
| Proceeds from Sale of PP&E | 0 | 75,411 | — | — | — | — | — | — |
| Cost of patents | (25,325) | (32,885) | (119,571) | (87,882) | (163,705) | (117,522) | (128,393) | (108,829) |
| NET CASH USED IN INVESTING ACTIVITIES | (3,801,298) | (850,738) | (4,338,128) | (5,179,323) | (4,819,597) | 7,422,413 | (18,578,665) | (2,945,051) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Repayment of borrowings and finance obligations | (113,940) | (44,902) | (36,615) | (37,239) | (103,335) | (4,957,936) | (30,725) | (172,484) |
| Repayments of Debt | — | — | — | — | — | — | 9,213 | 7,333 |
| Proceeds from Debt Issuance | — | — | — | — | 63,000 | 5,618,089 | — | — |
| Purchase of treasury stock | — | — | (1,759,457) | — | — | — | — | — |
| Sale of noncontrolling interest | 132,000 | — | — | — | — | — | — | — |
| Purchase of treasury stock | (1,806,646) | (2,505,832) | — | — | — | — | — | — |
| Distributions to noncontrolling interests | (5,682,555) | (5,630,336) | (5,776,200) | (5,822,232) | (6,570,000) | (5,565,000) | (6,600,000) | (6,135,000) |
| NET CASH USED IN FINANCING ACTIVITIES | (7,471,141) | (8,181,070) | (7,572,272) | (5,859,471) | (6,610,335) | (4,904,847) | (6,621,512) | (6,300,151) |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | — | — | — | — | — | 22,920,329 | (5,751,729) | 9,494,121 |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (7,557) | 5,061,486 | 2,556,730 | 4,262,566 | 7,658,069 | — | — | — |
| CASH AND CASH EQUIVALENTS – BEGINNING OF YEAR | — | — | — | 44,460,411 | 36,802,342 | 13,882,013 | 19,633,742 | 10,139,621 |
| CASH AND CASH EQUIVALENTS – END OF YEAR | — | — | — | — | 44,460,411 | 36,802,342 | 13,882,013 | 19,633,742 |
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | 56,341,193 | 51,279,707 | 48,722,977 | 44,460,411 | — | — | — | — |
| CASH AND CASH EQUIVALENTS - END OF YEAR | 56,333,636 | 56,341,193 | 51,279,707 | 48,722,977 | — | — | — | — |
| Net Income | — | 14,097,417 | 12,126,516 | 17,234,388 | 13,673,811 | 11,704,733 | 20,513,674 | 25,452,185 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.